Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Platelet-released growth factors can reduce inflammation in joint disease.

Pioglitazone combined with metformin or spironolactone improves PCOS symptoms and insulin resistance.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

The FDA approved a new Pfizer drug for hair loss in teens.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

The combination of Typhonium flagelliforme extract and natural interferons effectively reduces tumor growth in mice.

Polynucleotide gel injections help reduce hair loss and increase hair thickness in people with pattern hair loss, with few side effects.

IGFBP5 may be a potential target for Parkinson's treatment by reducing neuron death.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Gefitinib can cause rare scarring hair loss.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Ixekizumab effectively treats generalized pustular psoriasis.

Long-term high-dose fluconazole can cause reversible hair loss.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Nanoparticles may improve treatment for lung disease by targeting cells better and reducing side effects.

5α-reduced progestogens may reduce mood issues and brain damage linked to HIV-1 Tat.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Letrozole may help prevent seizures by reducing certain hormone levels.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.